Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 198

1.

Inhibition of PSMD4 blocks the tumorigenesis of hepatocellular carcinoma.

Cai MJ, Cui Y, Fang M, Wang Q, Zhang AJ, Kuai JH, Pang F, Cui XD.

Gene. 2019 Jun 20;702:66-74. doi: 10.1016/j.gene.2019.03.063. Epub 2019 Mar 28.

PMID:
30930224
2.

MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.

Dong X, Wang F, Xue Y, Lin Z, Song W, Yang N, Li Q.

Int J Mol Med. 2019 Mar;43(3):1417-1429. doi: 10.3892/ijmm.2019.4062. Epub 2019 Jan 14.

3.

Blueberry Malvidin-3-galactoside Suppresses Hepatocellular Carcinoma by Regulating Apoptosis, Proliferation, and Metastasis Pathways In Vivo and In Vitro.

Wang Y, Lin J, Tian J, Si X, Jiao X, Zhang W, Gong E, Li B.

J Agric Food Chem. 2019 Jan 16;67(2):625-636. doi: 10.1021/acs.jafc.8b06209. Epub 2019 Jan 7.

PMID:
30586992
4.

Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression.

Ding H, Wen Z, Sun G.

Med Sci Monit. 2018 Nov 9;24:8015-8021. doi: 10.12659/MSM.910944.

5.

AnnexinA7 down-regulation might suppress the proliferation and metastasis of human hepatocellular carcinoma cells via MAPK/ ERK pathway.

Zhao Y, Yang Q, Wang X, Ma W, Tian H, Liang X, Li X.

Cancer Biomark. 2018;23(4):527-537. doi: 10.3233/CBM-181651.

PMID:
30347600
6.
7.

Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.

Li F, Qi J, Qin C, Fu Z, Ren W.

Oncol Rep. 2018 Dec;40(6):3743-3751. doi: 10.3892/or.2018.6711. Epub 2018 Sep 18.

PMID:
30272302
8.

Knockdown of alpha-fetoprotein expression inhibits HepG2 cell growth and induces apoptosis.

Yang X, Chen L, Liang Y, Si R, Jiang Z, Ma B, Gao P.

J Cancer Res Ther. 2018 Sep;14(Supplement):S634-S643. doi: 10.4103/0973-1482.180681.

9.

miR-570 Inhibits Proliferation, Angiogenesis, and Immune Escape of Hepatocellular Carcinoma.

Lin Y, Liu S, Su L, Su Q, Lin J, Huang X, Wang C.

Cancer Biother Radiopharm. 2018 Aug;33(6):252-257. doi: 10.1089/cbr.2017.2389. Epub 2018 Jun 6.

PMID:
29874097
10.

Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.

Zhang ZL, Liu GC, Peng L, Zhang C, Jia YM, Yang WH, Mao L.

Gene Ther. 2018 Jul;25(4):284-296. doi: 10.1038/s41434-018-0016-9. Epub 2018 May 25.

PMID:
29802374
11.

Methyl ferulic acid exerts anti-apoptotic effects on L-02 cells via the ROS-mediated signaling pathway.

Li L, Zhong Y, Ma Z, Yang C, Wei H, Chen L, Li C, Wu D, Rong MZ, Li Y.

Int J Oncol. 2018 Jul;53(1):225-236. doi: 10.3892/ijo.2018.4379. Epub 2018 Apr 26.

PMID:
29749464
12.

Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis.

Qiu Z, Zhou J, Zhang C, Cheng Y, Hu J, Zheng G.

Braz J Med Biol Res. 2018;51(7):e7220. doi: 10.1590/1414-431x20187220. Epub 2018 May 7.

13.

Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells.

Liu L, Huang Z, Chen J, Wang J, Wang S.

J Cell Biochem. 2018 Aug;119(8):6633-6643. doi: 10.1002/jcb.26845. Epub 2018 Apr 25.

PMID:
29693750
14.

MicroRNA-26b inhibits the tumor growth of human liver cancer through the PI3K/Akt and NF-κB/MMP-9/VEGF pathways.

Feng Y, Zu LL, Zhang L.

Oncol Rep. 2018 May;39(5):2288-2296. doi: 10.3892/or.2018.6289. Epub 2018 Mar 1.

PMID:
29498407
15.

Saffron carotenoids inhibit STAT3 activation and promote apoptotic progression in IL-6-stimulated liver cancer cells.

Kim B, Park B.

Oncol Rep. 2018 Apr;39(4):1883-1891. doi: 10.3892/or.2018.6232. Epub 2018 Jan 25.

PMID:
29393468
16.

Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.

Chang W, Yu Z, Tian M, Lin X.

Oncol Rep. 2017 Dec;38(6):3489-3496. doi: 10.3892/or.2017.6046. Epub 2017 Oct 19.

PMID:
29130100
17.

Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.

Liu X, Xu J, Wang S, Yu X, Kou B, Chai M, Zang Y, Chen D.

Int J Oncol. 2017 Oct;51(4):1291-1299. doi: 10.3892/ijo.2017.4105. Epub 2017 Aug 29.

PMID:
28902369
18.

Zinc finger protein 307 functions as a tumor‑suppressor and inhibits cell proliferation by inducing apoptosis in hepatocellular carcinoma.

Liang Y, Li Q, Chen K, Ni W, Zhan Z, Ye F, Li Y, Fang Y, Zhang F, Chen L, Ding Y.

Oncol Rep. 2017 Oct;38(4):2229-2236. doi: 10.3892/or.2017.5868. Epub 2017 Aug 1.

PMID:
28765950
19.

FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.

Yang W, Wu Y, Wang C, Liu Z, Xu M, Zheng X.

Cancer Biomark. 2017 Jul 19;20(1):75-85. doi: 10.3233/CBM-170132.

PMID:
28655132
20.

Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC.

Xu JH, Chang WH, Fu HW, Shu WQ, Yuan T, Chen P.

Biochem Biophys Res Commun. 2017 Aug 26;490(3):920-926. doi: 10.1016/j.bbrc.2017.06.141. Epub 2017 Jun 24.

PMID:
28651931

Supplemental Content

Loading ...
Support Center